【Bora Pharma】February 2026 Revenue: NT$1.326 Billion (YoY -23.2%)
NQ Score
50/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Bora Pharmaceuticals released its revenue report for February 2026, posting NT$1.326 billion, a 23.2% decrease year-over-year. As a company specializing in pharmaceutical CDMO within the biotech and healthcare industry, this financial performance reflects the cyclical fluctuations of the sector.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What was Bora Pharma's reported revenue for February 2026?
- A: Bora Pharma's reported revenue for February 2026 was NT$1.326 billion.
- Q: How did Bora Pharma's February 2026 revenue compare to the previous year?
- A: Bora Pharma's February 2026 revenue experienced a year-over-year decrease of 23.2%.
- Q: What is the company ticker for Bora Pharma?
- A: The company ticker for Bora Pharma is 6472.
- Q: In which industry does Bora Pharma operate?
- A: Bora Pharma operates in the Biotechnology & Medical Care industry.
- Q: What was the exact monthly revenue figure for Bora Pharma in February 2026 in thousands of NTD?
- A: The exact monthly revenue figure for Bora Pharma in February 2026 was 1,326,086 thousand NTD.